Term: denosumab
IPA: dɪˈnɒs.jʊ.mab, dɛnˈoʊ.səˌmæb

==English==
{{wp}}

===Etymology===
From arbitrary prefix ''den-'' + {{af|en|-os-|-umab|t1=bone|t2=human monoclonal antibody}}.

===Pronunciation===
* {{IPA|en|/dɪˈnɒs.jʊ.mab/|a=RP}}
* {{IPA|en|/dɛnˈoʊ.səˌmæb/|/dəˈnɑs.jəˌmæb/|a=GA}}

===Noun===
{{en-noun|-}}

# {{lb|en|pharmaceutical drug}} A [[drug]] (trademarks ''Prolia'' and ''Xgera'') that is a [[genetically engineered]] [[monoclonal antibody]] that reduces {{w|bone resorption}} and increases [[bone]] mass by inhibiting [[osteoclast]] format